Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

Details for Australian Patent Application No. 2004233333 (hide)

Owner Avanir Pharmacueticals

Inventors Alisala, Kashinatham; Sircar, Jagadish C.; Nikoulin, Igor

Agent Davies Collison Cave

Pub. Number AU-A-2004233333

PCT Pub. Number WO2004/094471

Priority 60/464,667 22.04.03 US

Filing date 22 April 2004

Wipo publication date 4 November 2004

International Classifications

C07K 014/775 Peptides having more than 20 amino acids

A61K 038/05 Medicinal preparations containing peptides - Dipeptides

C07K 005/065 Peptides having up to four amino acids in a fully defined sequence

C07K 005/113 Peptides having up to four amino acids in a fully defined sequence

A61K 038/06 Medicinal preparations containing peptides - Tripeptides

A61K 038/17 Medicinal preparations containing peptides - from animals

C07K 005/107 Peptides having up to four amino acids in a fully defined sequence

C07K 005/087 Peptides having up to four amino acids in a fully defined sequence

A61K 038/07 Medicinal preparations containing peptides - Tetrapeptides

C07K 007/04 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 005/093 Peptides having up to four amino acids in a fully defined sequence

C07K 005/11 Peptides having up to four amino acids in a fully defined sequence

G01N 033/92 Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 005/09 Peptides having up to four amino acids in a fully defined sequence

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/094471 Priority application(s): WO2004/094471

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233334-2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo -[1,5-c]-pyrimidine adenosine A2a receptor antagonists

2004233329-Selective dimethylether recovery and recycle in a methanol-to-olefin process